433P Immune-related adverse events in extensive-stage small cell lung cancer treated with first-line chemo-immunotherapy: Thyroid versus non-thyroid toxicities in a real-world multicenter cohort from Poland and the Czech Republic
Conclusions: Baseline immune and transcriptomic features are linked with durable clinical benefit in ES-SCLC pts treated with chemo-IT and may guide personalized ITbased treatment.
Authors
- Katarzyna Królak-Nowak
- Marek Ziobro (ORCID: https://orcid.org/0000-0002-6870-9492)
- Rafał Stando (ORCID: https://orcid.org/0000-0002-2543-8370)
- Damian Tworek (ORCID: https://orcid.org/0000-0001-9862-6703)
- Ondřej Bílek (ORCID: https://orcid.org/0000-0001-9581-3423)
- L.M. Kuncman
- M. Puskulluoglu
- A. Roman
- M.E. Bilski
- M. Svaton
- K. Smólka
- M. Lisik-Habib
- P. Chojnacki
- J. Fijuth
Institutions
- Lodz University of Technology (PL)
- Copernicus Memorial Hospital (PL)
- University Hospital Plzen (CZ)
- Masaryk Memorial Cancer Institute (CZ)
- National Institute of Oncology (HU)
- Holy Cross University (PL)
- Medical University of Lodz (PL)
- Lublin Oncology Center (PL)
- German Center for Lung Research (DE)
- Krakow Cardiovascular Research Institute (PL)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.esmoop.2026.106747
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00